These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 24804299)
1. The overexpression of 14-3-3ζ and Hsp27 promotes non–small cell lung cancer progression. Zhao GY; Ding JY; Lu CL; Lin ZW; Guo J Cancer; 2014 Mar; 120(5):652-63. PubMed ID: 24804299 [TBL] [Abstract][Full Text] [Related]
2. Ginkgo biloba extract decreases non-small cell lung cancer cell migration by downregulating metastasis-associated factor heat-shock protein 27. Tsai JR; Liu PL; Chen YH; Chou SH; Yang MC; Cheng YJ; Hwang JJ; Yin WH; Chong IW PLoS One; 2014; 9(3):e91331. PubMed ID: 24618684 [TBL] [Abstract][Full Text] [Related]
3. 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma. Zhao Y; Qiao W; Wang X; Yin H; Cui J; Cui Y; Chen X; Hu J; Lu H; Meng Q; Wang Y; Cai L Oncotarget; 2016 Dec; 7(50):82972-82984. PubMed ID: 27764818 [TBL] [Abstract][Full Text] [Related]
4. 14-3-3ζ promotes lung cancer cell invasion by increasing the Snail protein expression through atypical protein kinase C (aPKC)/NF-κB signaling. Tong S; Xia T; Fan K; Jiang K; Zhai W; Li JS; Wang SH; Wang JJ Exp Cell Res; 2016 Oct; 348(1):1-9. PubMed ID: 27554601 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Fan T; Li R; Todd NW; Qiu Q; Fang HB; Wang H; Shen J; Zhao RY; Caraway NP; Katz RL; Stass SA; Jiang F Cancer Res; 2007 Aug; 67(16):7901-6. PubMed ID: 17699796 [TBL] [Abstract][Full Text] [Related]
6. Loss of Par3 promotes lung adenocarcinoma metastasis through 14-3-3ζ protein. Song T; Tian X; Kai F; Ke J; Wei Z; Jing-Song L; Si-Hua W; Jian-Jun W Oncotarget; 2016 Sep; 7(39):64260-64273. PubMed ID: 27588399 [TBL] [Abstract][Full Text] [Related]
7. Increased HSP27 correlates with malignant biological behavior of non-small cell lung cancer and predicts patient's survival. Sheng B; Qi C; Liu B; Lin Y; Fu T; Zeng Q Sci Rep; 2017 Oct; 7(1):13807. PubMed ID: 29062135 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications. Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422 [TBL] [Abstract][Full Text] [Related]
9. ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer. Zhou X; Zhou R; Zhou H; Li Q; Hong J; Meng R; Zhu F; Zhang S; Dai X; Peng G; Wu G; Li Z Cell Physiol Biochem; 2018; 45(5):1827-1839. PubMed ID: 29510376 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer. Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777 [TBL] [Abstract][Full Text] [Related]
12. p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancer. Zhao H; Zhang D; Yang L; Wang E Mol Carcinog; 2018 Jan; 57(1):89-96. PubMed ID: 28898462 [TBL] [Abstract][Full Text] [Related]
13. The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer. Liu CL; Chen SF; Wu MZ; Jao SW; Lin YS; Yang CY; Lee TY; Wen LW; Lan GL; Nieh S Oncotarget; 2016 Mar; 7(12):14279-90. PubMed ID: 26872057 [TBL] [Abstract][Full Text] [Related]
14. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of MUC1 by its novel activator 14-3-3ζ promotes tumor invasion and indicates poor prognosis in lung adenocarcinoma. Xue M; Tao W Oncol Rep; 2017 Nov; 38(5):2637-2646. PubMed ID: 28901525 [TBL] [Abstract][Full Text] [Related]
17. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC. Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753 [TBL] [Abstract][Full Text] [Related]
18. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells. Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer. Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417 [TBL] [Abstract][Full Text] [Related]
20. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer. Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]